Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stomach ultrasound may predict Post-Surgery complications

NCT ID NCT07063069

Diagnosis Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study explores whether measuring stomach size with ultrasound can predict nausea, vomiting, and pneumonia after major abdominal surgery. Researchers will compare stomach diameter before and after surgery in 150 patients. The goal is to find a simple way to identify who might need early help, such as a nasogastric tube, to prevent complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
abdominal ultrasound
What this could lead to
If successful, this could give doctors a simple, non-invasive way to identify patients at high risk of postoperative nausea, vomiting, or pneumonia, allowing earlier treatment.
What could go wrong
This is an observational study with 150 patients, so results may not apply to everyone. The link between stomach size and complications is still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Major patient * Indication for major abdominal surgery (submesocolic, parietal, left pancreas or liver) * Patient affiliated to or benefiting from a social security scheme Non-inclusion criteria * Patient refusal to participate in study * Need for immediate post-operative ICU stay * Surgery performed as an emergency * Esophageal, gastric or cephalic pancreatic surgery * Person deprived of liberty by judicial or administrative decision * Person under compulsory psychiatric care Exclusion Criteria: * Discharge with nasogastric tube * Immediate admission to post-operative intensive care unit

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patient with indication for major abdominal submesocolic, parietal, left pancreatic or liver surger are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Patient with indication for major abdominal submesocolic, parietal, left pancreatic or liver surger

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital of Angers

    RECRUITING

    Angers, France